Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry. (Q40974681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author

Pablo Martínez Camblor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Blanca Xicoy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mar Tormo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

David Valcarcel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

T Bernal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J Sánchez-García

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

R de Paz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

E Luño

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

B Nomdedeu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

M T Ardanaz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

C Pedro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

M L Amigo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

C del Cañizo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J Bargay

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

S Brunet

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

L Benlloch

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

G Sanz

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Spanish Group on Myelodysplastic Syndromes

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PETHEMA Foundation

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Spanish Society of Hematology

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

6 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1875-1881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2015.115

7 March 2020

exact match

0 references

cites work

Myelodysplastic Syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Revised international prognostic scoring system for myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Nomenclature evolution: Changes in the ISCN from the 2005 to the 2009 edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Observational studies: the hazard and other gods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

A Proportional Hazards Model for the Subdistribution of a Competing Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Use of phosphate-binding agents is associated with a lower risk of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.115

Impact of age and comorbidity in myelodysplastic syndromes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25943181

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25943181

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25943181

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2015.115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 March 2020

1021869837

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943181%20AND%20SRC:MED&resulttype=core&format=json